0001192482-19-000333.txt : 20190812 0001192482-19-000333.hdr.sgml : 20190812 20190812153752 ACCESSION NUMBER: 0001192482-19-000333 CONFORMED SUBMISSION TYPE: D/A PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20190812 DATE AS OF CHANGE: 20190812 EFFECTIVENESS DATE: 20190812 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Palvella Therapeutics, Inc. CENTRAL INDEX KEY: 0001742961 IRS NUMBER: 812228053 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D/A SEC ACT: 1933 Act SEC FILE NUMBER: 021-337141 FILM NUMBER: 191016292 BUSINESS ADDRESS: STREET 1: 125 STRAFFORD AVENUE STREET 2: STE 360 CITY: WAYNE STATE: PA ZIP: 19087 BUSINESS PHONE: 800-484-0260 MAIL ADDRESS: STREET 1: 125 STRAFFORD AVENUE STREET 2: STE 360 CITY: WAYNE STATE: PA ZIP: 19087 D/A 1 primary_doc.xml X0708 D/A LIVE 0001742961 Palvella Therapeutics, Inc. 125 STRAFFORD AVENUE STE 360 WAYNE PA PENNSYLVANIA 19087 484-253-1464 DELAWARE None None Corporation true 2015 Wesley H. Kaupinen 125 Strafford Avenue Ste 360 Wayne PA PENNSYLVANIA 19087 Executive Officer Director Michael Christopher 125 Strafford Avenue Ste 360 Wayne PA PENNSYLVANIA 19087 Director Todd Davis 125 Strafford Avenue Ste 360 Wayne PA PENNSYLVANIA 19087 Director Timothy Henkel 125 Strafford Avenue Ste 360 Wayne PA PENNSYLVANIA 19087 Director Elaine Heron 125 Strafford Avenue Ste 360 Wayne PA PENNSYLVANIA 19087 Director George Jenkins 125 Strafford Avenue Ste 360 Wayne PA PENNSYLVANIA 19087 Director John Doux 125 Strafford Avenue Ste 360 Wayne PA PENNSYLVANIA 19087 Director Biotechnology Decline to Disclose 06b true 0001742961-19-000001 2019-03-29 false true false 0 5000000 4791954 208046 false 47 0 0 0 false Palvella Therapeutics, Inc. /s/ Wesley H. Kaupinen Wesley H. Kaupinen President and CEO 2019-08-12